Skip to main content
. 2020 Jul 21;161(9):bqaa124. doi: 10.1210/endocr/bqaa124

Table 2.

Fos+ Cells in Piriform Cortex, Medial Amygdala, and Preoptic Area

DMSO PCB VIN
Mean SEM N Mean SEM N Mean SEM N
Anterior Piriform Cortex
Females 21.17 3.63 6 26.33 4.13 9 23.78 4.31 9
Males 13.25 2.86 8 15.42 3.41 9 16.61 3.13 9
Posterior Piriform Cortex
Females 22.33 1.17 6 24.33 1.68 9 21.50 2.38 8
Males 14.56 3.19 9 16.70 2.81 10 14.64 2.65 11
Preoptic Area
Females 10.20 1.07 5 8.33 0.69 9 8.67 1.04 9
Males 1.84 0.49 8 4.28 1.72 9 2.03 0.84 9
Medial Amygdala PV
Females 10.10 1.22 6 10.34 2.34 7 10.53 1.77 8
Males 5.58 0.88 9 7.42 1.27 9 5.87 1.53 9
Medial Amygdala PD
Females 8.97 0.98 6 7.81 1.28 7 9.76 1.66 8
Males 4.13 0.67 9 3.72 0.70 9 2.92 0.73 9

The percentage of Fos+ cells in the anterior piriform cortex, posterior piriform cortex, preoptic area, posteroventral (PV) medial amygdala, and the posterodorsal (PD) medial amygdala. There were no treatment differences in any of the regions investigated with in either females or males.

Abbreviations: DMSO, dimethyl sulfoxide; PCB, polychlorinated biphenyl; VIN, vinclozolin.